StevenMAlbeldaMD
Pulmonology • Philadelphia, PACritical Care Medicine, Pleural Disease
Professor, Medicine, Perelman School of Medicine
Dr. Albelda is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3450 Hamilton Walk
228 Stemmler Hall
Philadelphia, PA 19104Phone+1 215-573-9933Fax+1 215-746-0376
Education & Training
University of Pennsylvania Health SystemFellowship, Pulmonary Disease and Critical Care Medicine, 1982 - 1985- University of Pennsylvania Health SystemResidency, Internal Medicine, 1979 - 1982
Perelman School of Medicine at the University of PennsylvaniaClass of 1979
Certifications & Licensure
PA State Medical License 1981 - 2018
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1995
Publications & Presentations
PubMed
- 167 citationsChimeric antigen receptor T-cell therapy for solid tumorsKheng Newick, Edmund K. Moon, Steven M. Albelda
Molecular Therapy Oncolytics. 2016-01-01 - 486 citationsCAR T cells produced in vivo to treat cardiac injury.Joel G Rurik, István Tombácz, Amir Yadegari, Pedro O Méndez Fernández, Swapnil V Shewale
Science. 2022-01-07 - 64 citationsCAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn.Steven M Albelda
Nature Reviews. Clinical Oncology. 2024-01-01
Other
- Clinical presentation, diagnosis, and staging of malignant pleural mesotheliomaAlbelda SM, Sterman DH, Kaiser LR, Litzky LA
http://www.uptodate.com/contents/clinical-presentation-diagnosis-and-staging-of-malignant-pleural-me
UpToDate, Wolters Kluwer Health - 2013-01-16 - Epidemiology of malignant mesotheliomaAlbelda SM, Sterman DH, Kaiser LR, Litzky LA
http://www.uptodate.com/contents/epidemiology-of-malignant-mesothelioma
UpToDate, Wolters Kluwer Health - 2012-08-24 - Treatment approaches for localized malignant pleural mesothelioma and solitary fibrous tumor of the pleuraAlbelda SM, Sterman DH, Kaiser LR, Litzky LA
http://www.uptodate.com/contents/treatment-approaches-for-localized-malignant-pleural-mesothelioma-a
UpToDate, Wolters Kluwer Health - 2012-10-31
Press Mentions
Verismo Therapeutics Appoints Steven Albelda, MD, to Scientific Advisory BoardNovember 9th, 2021
Advanced Gene Therapy TR002 Moves to Phase III Clinical Trial for MesotheliomaSeptember 5th, 2019
Mesothelioma Clinical Trial Targets Latest Gene TherapySeptember 4th, 2019- Join now to see all
Grant Support
- Training In Pulmonary ImmunologyNational Heart, Lung, And Blood Institute2000–2011
- Preclinical StudiesNational Cancer Institute2006–2010
- Immuno/Immunogene Therapies For Thoracic MalignanciesNational Cancer Institute2006–2010
- Genetic Influence On Incidence Of Acute Lung InjuryNational Heart, Lung, And Blood Institute2005–2009
- AdministrationNational Cancer Institute2006
- The Role Of Pecam In Models Of Lung InjuryNational Heart, Lung, And Blood Institute2002–2005
- Gene Therapy For Malignant MesotheliomaNational Cancer Institute1995–2004
- Vector Development /Preclinical TestingNational Cancer Institute2000–2002
- Pecam And Calcium Signaling And TransmigrationNational Heart, Lung, And Blood Institute1999–2002
- Ovarian Selective Adenoviral Vector For Gene Therapy Of Ovarian CancerNational Cancer Institute1999–2002
- Efficacy And Mechanisms Of Ad.Rsvtk-Mediated Tumor Eradication--Disease ModelNational Cancer Institute1996–1999
- Endocam/Pecam--A Novel Vascular Cell Adhesion MoleculeNational Heart, Lung, And Blood Institute1995–1999
- Pilot Study--Model Of Human Bronchus To Study Gene Transfer In Cystic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases1997
- Competitive Supplement To Po1 CA 66726--Gene TherapyNational Cancer Institute1997
- Human-Mouse Chimeras--A Model For Vascular Cell BiologyNational Heart, Lung, And Blood Institute1993–1997
- Endocam/Pecam--A Novel Vascular Cell Adhesion MoleculeNational Heart, Lung, And Blood Institute1991–1994
- Endothelial Cell-Blood InteractionsNational Heart, Lung, And Blood Institute1988–1989
- Endothelial Cell - Blood InteractionsNational Heart, Lung, And Blood Institute1985–1987
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
